Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
Klaus Rajewsky(Boston Biomedical Research Institute), Alain Fischer(Inserm), Werner Müller(University of Cologne), Delphine Guy‐Grand(Hôpital Necker-Enfants Malades)
Cited by 872
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k